Huaren Pharmaceutical Co Ltd Asset Resilience Ratio

Latest as of September 2020: 0.10%

Huaren Pharmaceutical Co Ltd asset resilience ratio. Huaren Pharmaceutical Co Ltd (300110) has an Asset Resilience Ratio of 0.10% as of September 2020. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Huaren Pharmaceutical Co Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥3.00 Million

≈ $438.99K USD Cash + Short-term Investments

Total Assets

CN¥2.87 Billion

≈ $420.66 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Huaren Pharmaceutical Co Ltd (2017–2019)

Asset resilience ratio of Huaren Pharmaceutical Co Ltd from 2017 to 2019. This chart shows how Huaren Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read Huaren Pharmaceutical Co Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Huaren Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 300110 total asset value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥3.00 Million	0.1%
Total Liquid Assets	CN¥3.00 Million	0.10%

Asset Resilience Insights

Limited Liquidity: Huaren Pharmaceutical Co Ltd maintains only 0.10% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Huaren Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Huaren Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Ajanta Pharma Limited NSE:AJANTPHARM	Drug Manufacturers - Specialty & Generic	14.99%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Jiangsu Nhwa Pharmaceutical Co Ltd SHE:002262	Drug Manufacturers - Specialty & Generic	26.45%
Porton Fine Chemicals Ltd SHE:300363	Drug Manufacturers - Specialty & Generic	6.85%
Jubilant Pharmova Limited NSE:JUBLPHARMA	Drug Manufacturers - Specialty & Generic	1.26%

Huaren Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2017–2019)

Huaren Pharmaceutical Co Ltd asset resilience ratio by year from 2017 to 2019. The table below shows the annual Asset Resilience Ratio data for Huaren Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2019-12-31	0.11%	CN¥2.85 Million ≈ $417.04K	CN¥2.71 Billion ≈ $396.60 Million	-0.28pp
2017-12-31	0.38%	CN¥11.11 Million ≈ $1.63 Million	CN¥2.89 Billion ≈ $422.47 Million	--

pp = percentage points

About Huaren Pharmaceutical Co Ltd

SHE:300110 China Drug Manufacturers - Specialty & Generic

Market Cap

$460.17 Million

CN¥3.14 Billion CNY

Market Cap Rank

#12333 Global

#3587 in China

Share Price

CN¥2.66

Change (1 day)

-2.21%

52-Week Range

CN¥2.47 - CN¥3.95

All Time High

CN¥13.46